These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 24897995)

  • 21. Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study.
    Borzio M; Fornari F; De Sio I; Andriulli A; Terracciano F; Parisi G; Francica G; Salvagnini M; Marignani M; Salmi A; Farinati F; Carella A; Pedicino C; Dionigi E; Fanigliulo L; Cazzaniga M; Ginanni B; Sacco R;
    Future Oncol; 2013 Feb; 9(2):283-94. PubMed ID: 23414477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic hepatitis B and hepatocellular carcinoma.
    McClune AC; Tong MJ
    Clin Liver Dis; 2010 Aug; 14(3):461-76. PubMed ID: 20638025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison.
    Cho Y; Kim BH; Park JW
    Clin Mol Hepatol; 2023 Apr; 29(2):252-262. PubMed ID: 36907570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma in viral hepatitis: improving standard therapy.
    Masuzaki R; Yoshida H; Tateishi R; Shiina S; Omata M
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1137-51. PubMed ID: 19187872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2014 KLCSG-NCC Korea Practice Guidelines for the management of hepatocellular carcinoma: HCC diagnostic algorithm.
    Lee JM; Park JW; Choi BI
    Dig Dis; 2014; 32(6):764-77. PubMed ID: 25376295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria?
    Chow PK
    J Gastroenterol Hepatol; 2012 Mar; 27(3):452-7. PubMed ID: 22142283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.
    ; ; ; ; ; ; ; ; ;
    J Formos Med Assoc; 2018 May; 117(5):381-403. PubMed ID: 29074347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidisciplinary management of nonresectable hepatocellular carcinoma.
    Park HC; Seong J; Tanaka M; Zeng ZC; Lim HY; Guan S; Bae SH; Tak WY
    Oncology; 2011; 81 Suppl 1():134-40. PubMed ID: 22212947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver Cancer Working Group report.
    Kudo M; Han KH; Kokudo N; Cheng AL; Choi BI; Furuse J; Izumi N; Park JW; Poon RT; Sakamoto M
    Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i19-27. PubMed ID: 20870915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Practice guidelines for management of hepatocellular carcinoma 2009].
    Korean Liver Cancer Study Group and National Cancer Center, Korea
    Korean J Hepatol; 2009 Sep; 15(3):391-423. PubMed ID: 19783891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation for hepatocellular carcinoma in Asia.
    de Villa V; Lo CM
    Oncologist; 2007 Nov; 12(11):1321-31. PubMed ID: 18055852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation for hepatocellular carcinoma.
    Hemming AW; Nelson DR; Reed AI
    Minerva Chir; 2002 Oct; 57(5):575-85. PubMed ID: 12370659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
    Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of hepatocellular carcinoma].
    Pache I; Bize P; Halkic N; Montemurro M; Giostra E; Majno P; Moradpour D
    Rev Med Suisse; 2010 Jan; 6(233):198-202. PubMed ID: 20214192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
    Lao OB; Weissman J; Perkins JD
    Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of hepatocellular carcinoma in Japan and Korea. A review.
    Kim SR; Kudo M; Hino O; Han KH; Chung YH; Lee HS;
    Oncology; 2008; 75 Suppl 1():13-6. PubMed ID: 19092267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Australian recommendations for the management of hepatocellular carcinoma: a consensus statement.
    Lubel JS; Roberts SK; Strasser SI; Thompson AJ; Philip J; Goodwin M; Clarke S; Crawford DH; Levy MT; Shackel N
    Med J Aust; 2021 Jun; 214(10):475-483. PubMed ID: 33314233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
    Omata M; Ashcavai M; Liew CT; Peters RL
    Gastroenterology; 1979 Feb; 76(2):279-87. PubMed ID: 215488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epidemiology and clinical aspects of primary liver tumors].
    Berndt H
    Z Arztl Fortbild (Jena); 1991 Dec; 85(23):1135-8. PubMed ID: 1663677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.